WaferGen Bio-systems, Inc. engages in the development, manufacture and marketing of SmartChip System, a genetic analysis platform used for profiling and validating molecular biomarkers in the life sciences and pharmaceutical drug discovery industries. SmartChip System The company’s SmartChip products are aimed at researchers who perform genetic analysis, primarily at pharmaceutical and biotech companies, academic and private research centers and diagnostics companies involved in biomarker discovery and genetic research. The company is primarily focused on marketing a flexible, open format genetic analysis system, the WaferGen SmartChip System, which provides a range of high throughput capabilities, including mRNA (messenger Ribonucleic acid), microRNA and lncRNA expression level measurement, as well as SNP genotyping. In 2010, the company launched its first generation SmartChip 5K System, which is a real-time polymerase chain reaction (real-time PCR)2 tool enabling scientists to study genes simultaneously clustered in gene specific pathways. In 2012, the company launched the SmartChip MyDesign System, which is the second-generation instrument with significantly upgraded capabilities. The SmartChip System’s high density, nanoliter-scale format provide throughput levels that facilitate the development of life science clinical research solutions at a fraction of the time. Apollo 324 System The Apollo 324 System is a compact, walk-away automation platform offering DNA, RNA-Seq, and ChIP-Seq library preparation kits for analysis on popular NGS platforms from Illumina (GA, HiSeq and MiSeq), LIFE (Ion Proton and Ion Torrent PGM), and Roche (GS Junior, GS FLX and GS FLX+). The intuitive and easy-to-use PrepX automation protocols and reagent kits enable the set-up of a run with as little as 15 minutes of hands-on time. Research and Development The company’s research and development expenses were approximately $6.72 million, as of December 31, 2014. Intellectual Property The company has four patents issued and five pending in the U.S. with respect to its SmartChip products and technologies, and other pending SmartChip-related patent applications worldwide. The company also has one U.S. patent pending with respect to its Apollo 324 products and technologies. Competition The company’s competitors include Illumina, Inc.; Life Technologies Corporation; Fluidigm Corporation; Agilent Technologies, Inc.; and PerkinElmer, Inc. History WaferGen Bio-systems, Inc. was founded in 2002.
wafergen bio-systems inc
7400 Paseo Padre Parkway
Fremont, CA 94555
|Enzo Biochem Inc||$4.63 USD||+0.10|
|Exiqon A/S||kr11.70 DKK||+0.10|
|HTG Molecular Diagnostics Inc||$5.15 USD||+0.065|
|NanoString Technologies Inc||$15.50 USD||+0.04|
|Sequenom Inc||$1.78 USD||+0.01|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact WAFERGEN BIO-SYSTEMS INC, please visit www.wafergen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.